130 related articles for article (PubMed ID: 21906954)
1. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
[TBL] [Abstract][Full Text] [Related]
2. Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
Lazzarato L; Donnola M; Rolando B; Marini E; Cena C; Coruzzi G; Guaita E; Morini G; Fruttero R; Gasco A; Biondi S; Ongini E
J Med Chem; 2008 Mar; 51(6):1894-903. PubMed ID: 18293898
[TBL] [Abstract][Full Text] [Related]
3. Nitrooxyacyl derivatives of salicylic acid: aspirin-like molecules that covalently inactivate cyclooxygenase-1.
Cena C; Tosco P; Marini E; Lazzarato L; Piccinini M; Ramondetti C; Lupino E; Fruttero R; Gasco A
ChemMedChem; 2011 Mar; 6(3):523-30. PubMed ID: 21360823
[TBL] [Abstract][Full Text] [Related]
4. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
[TBL] [Abstract][Full Text] [Related]
5. Nitrooxymethyl-substituted analogues of rofecoxib: synthesis and pharmacological characterization.
Boschi D; Cena C; Di Stilo A; Rolando B; Manzini P; Fruttero R; Gasco A
Chem Biodivers; 2010 May; 7(5):1173-82. PubMed ID: 20491074
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble nitric-oxide-releasing acetylsalicylic acid (ASA) prodrugs.
Rolando B; Lazzarato L; Donnola M; Marini E; Joseph S; Morini G; Pozzoli C; Fruttero R; Gasco A
ChemMedChem; 2013 Jul; 8(7):1199-209. PubMed ID: 23754790
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and antithrombotic activity of acetylsalicyl ferulic acid-coupling furoxans and nitrates].
Zhou Z; Jiang LY; Zhang YH; Ji H; Sun Y; Peng SX
Yao Xue Xue Bao; 2006 Nov; 41(11):1050-6. PubMed ID: 17262946
[TBL] [Abstract][Full Text] [Related]
8. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.
Turnbull CM; Cena C; Fruttero R; Gasco A; Rossi AG; Megson IL
Br J Pharmacol; 2006 Jun; 148(4):517-26. PubMed ID: 16702997
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
11. New nitric oxide or hydrogen sulfide releasing aspirins.
Lazzarato L; Chegaev K; Marini E; Rolando B; Borretto E; Guglielmo S; Joseph S; Di Stilo A; Fruttero R; Gasco A
J Med Chem; 2011 Aug; 54(15):5478-84. PubMed ID: 21688846
[TBL] [Abstract][Full Text] [Related]
12. Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin.
Cena C; Lolli ML; Lazzarato L; Guaita E; Morini G; Coruzzi G; McElroy SP; Megson IL; Fruttero R; Gasco A
J Med Chem; 2003 Feb; 46(5):747-54. PubMed ID: 12593655
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
14. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
Chegaev K; Lazzarato L; Tosco P; Cena C; Marini E; Rolando B; Carrupt PA; Fruttero R; Gasco A
J Med Chem; 2007 Apr; 50(7):1449-57. PubMed ID: 17335184
[TBL] [Abstract][Full Text] [Related]
15. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib prodrugs possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Velázquez CA; Huang Z; Dong Y; Das D; Yu G; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Aug; 20(15):4544-9. PubMed ID: 20576432
[TBL] [Abstract][Full Text] [Related]
17. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
[TBL] [Abstract][Full Text] [Related]
20. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]